Cure51

Precision oncology company leveraging AI and data science to identify new cancer treatments by studying exceptional responders - patients who have unexpectedly positive responses to treatments.

Location
Paris, France
Founded
2021
Investors
1
Categories
digital-medicine, ai, oncology, precision-medicine, biotech

Investors

NameLocationTypeStagesPortfolio
Sofinnova PartnersParis, Francebiotech-focused
seedseries-a+3
23